Cabaletta Bio
Engineered CAAR T cell therapies for autoimmune disease treatment
- Sector
- Biotech
- Headquarters
- VILLANOVA, PA
- Founded
- 2017
- Latest Form D
- $50M, Jan 2019
- Total capital
- $88.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $88.3M
- 2 Form D · last Jan 2019
- 93 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 11 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$50M
- Private capital raisedForm D · SEC · 1st filing$38.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Brian DanielsDirectorNamed in SEC Form D filings
- Dan GeffkenExecutive OfficerNamed in SEC Form D filings
- Mark SimonDirectorNamed in SEC Form D filings
- Steven NichtbergerExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 11- PendingMethods And Compositions For Treating Autoimmune DiseasesUSPTOApplication 19470700
- PendingMethods And Compositions For Treating Autoimmune DiseasesUSPTOApplication 19470703
- PendingCD19 Antibodies And Methods Of Using SameUSPTOApplication PCTUS2025031753
Show all 11 patent records
- Methods And Compositions For Treating Autoimmune DiseasesApplication 19470700Pending
- Methods And Compositions For Treating Autoimmune DiseasesApplication 19470703Pending
- CD19 Antibodies And Methods Of Using SameApplication PCTUS2025031753Pending
- Methods And Compositions For Treating Autoimmune DiseasesApplication PCTUS2025020635Pending
- CD19 Antibodies And Methods Of Using SameApplication 63654521Pending
- Methods And Compositions For Preparing Genetically Modified Immune CellsApplication 63644757Pending
- Methods And Compositions For Treating Autoimmune DiseasesApplication PCTUS2024022337Pending
- Methods And Compositions For Treating Autoimmune DiseasesApplication PCTUS2024022338Pending
- Methods And Compositions For Treating Autoimmune DiseasesApplication 63567674Pending
- Methods And Compositions For Treating Autoimmune DiseasesApplication 63493133Pending
- Methods And Compositions For Treating Autoimmune DiseasesApplication 63493136Pending
Related companies, and why
- COGENTIS THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- VIROGENOMICS BIODEVELOPMENT, INC.Similar federal contract value in Biotech · null in contracts
- NAVIGEN, INC.Similar federal contract value in Biotech · null in contracts
- Trotana TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Corvus PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
- Charm TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .